Teprotumumab Effectively Reduces Proptosis in Active Thyroid Eye Disease

Teprotumumab effectively reduces proptosis in patients with active thyroid eye disease, according to phase 3 confirmatory trial data presented at the AACE 28th Annual Scientific & Clinical Congress. more

Hypothyroidism a Risk Factor for Mortality in Congestive Heart Failure

Hypothyroidism is a risk factor for increased length of hospital stay and mortality in patients with congestive heart failure (CHF), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. more

Novel Cardiometabolic Staging Tool Predicts T2D Risk in Diverse Population

A weighted cardiometabolic disease staging risk score can be used to quantify race- and sex-specific type 2 diabetes risk in a large, diverse population, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.  more

Anxiety More Common Than Depression in Euthyroid Patients With Thyroid Disease

Significantly more euthyroid patients with thyroid disease suffer from anxiety compared with depression, regardless of whether they have Hashimoto thyroiditis autoimmunity, according to research results presented at the AACE 28th Annual Scientific & Clinical Congress.  more

Levoketoconazole Improves Biochemical and Clinical Parameters in Patients With Cushing Syndrome

Biochemical markers and clinical signs and symptoms of endogenous Cushing syndrome improved after 6 months of levoketoconazole therapy, according to phase 3 study results presented at the AACE 28th Annual Scientific & Clinical Congress.  more

Cortisol Pumps May Be Viable Option to Reduce Adrenal Crisis in Severe Adrenal Insufficiency

The use of an insulin pump to deliver continuous pulsatile cortisol may be a viable treatment option in patients with severe adrenal insufficiency who are unresponsive to oral corticosteroids, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.  more

Abaloparatide Followed by Alendronate Shows Promising Results for Women With Osteoporosis, T2D

Abaloparatide followed by alendronate treatment may improve bone mineral density (BMD) in women with postmenopausal osteoporosis and type 2 diabetes (T2D), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.  more

Linagliptin Does Not Increase Adverse Renal Events in Patients With T2D, Kidney Disease

Treatment with linagliptin in patients with type 2 diabetes (T2D) and cardiovascular and/or kidney disease had no impact on risk for cardiovascular or kidney events or hospitalization for heart failure, according to results of the CARMELINA study (Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus) presented at the AACE 28th Annual Scientific & Clinical Congress.  more

Type 2 Diabetes Associated With Short-Term Risk for Fracture

Type 2 diabetes (T2D) is associated with increased risk for fractures in the short term but not in the long term, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. more

In-hospital diabetic ketoacidosis mortality risk higher on the weekend

Findings presented at the AACE 28th Annual Scientific & Clinical Congress showed that seeking hospital care for diabetic ketoacidosis during the weekend as opposed to during the week may increase mortality risk. more